The proportion of total CD59 present on the EC plasma membrane, which is the site of its protective activity, was reduced in OSA patients (n = 10) compared with controls (n = 10) (two-sided exact permutation test, P = 0.01) (Fig. 2, D and E). The gene discussed is CD59; the disease is obstructive sleep apnea syndrome.